Virax Biolabs Group (VRAX) Short Interest Ratio & Short Volume $0.62 +0.01 (+0.95%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$0.62 +0.01 (+1.40%) As of 10/3/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Short Interest DataVirax Biolabs Group (VRAX) has a short interest of 139,500 shares, representing 3.58% of the float (the number of shares available for trading by the public). This marks a -60.25% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 381,140 shares to cover all short positions.Current Short Interest139,500 sharesPrevious Short Interest350,900 sharesChange Vs. Previous Month-60.25%Dollar Volume Sold Short$90.14 thousandShort Interest Ratio0.2 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares4,340,000 sharesFloat Size3,900,000 sharesShort Percent of Float3.58%Today's Trading Volume146,957 sharesAverage Trading Volume381,140 sharesToday's Volume Vs. Average39% Short Selling Virax Biolabs Group? Sign up to receive the latest short interest report for Virax Biolabs Group and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRAX Short Interest Over TimeVRAX Days to Cover Over TimeVRAX Percentage of Float Shorted Over Time Virax Biolabs Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2025139,500 shares $90.14 thousand -60.3%3.6%0.2 $0.65 8/31/2025350,900 shares $212.58 thousand +758.0%9.0%0.7 $0.61 8/15/202540,900 shares $31.49 thousand +176.4%1.1%0.1 $0.77 7/31/202514,800 shares $11.99 thousand -35.9%0.4%0.2 $0.81 7/15/202523,100 shares $20.10 thousand -82.4%0.6%0.3 $0.87 6/30/2025131,000 shares $103.71 thousand +529.8%0.9%1 $0.79 6/15/202520,800 shares $18.36 thousand -57.6%0.5%0.2 $0.88 5/31/202549,100 shares $46.65 thousand -55.9%1.2%0.3 $0.95 5/15/2025111,400 shares $118.08 thousand -23.2%2.8%0.6 $1.06 4/30/2025145,100 shares $142.23 thousand -43.9%3.6%0.6 $0.98 Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025258,800 shares $274.33 thousand +85.9%6.4%1.1 $1.06 3/31/2025139,200 shares $158.69 thousand -12.2%3.4%0.6 $1.14 3/15/2025158,600 shares $217.28 thousand -21.7%3.9%0.4 $1.37 2/28/2025202,600 shares $338.34 thousand +12.3%5.0%0.5 $1.67 2/15/2025180,400 shares $343.54 thousand +205.8%4.5%0.5 $1.90 1/31/202559,000 shares $99.71 thousand -45.9%1.5%0.2 $1.69 1/15/2025109,000 shares $225.63 thousand -33.9%2.7%0.1 $2.07 12/31/2024164,900 shares $371.03 thousand +85.5%4.1%0.1 $2.25 12/15/202488,900 shares $139.57 thousand -38.5%2.2%0.1 $1.57 11/30/2024144,600 shares $284.86 thousand -49.1%3.6%0.1 $1.97 11/15/2024284,000 shares $508.36 thousand -36.4%7.0%0.1 $1.79 10/31/2024446,500 shares $924.26 thousand +92.6%11.0%0.1 $2.07 10/15/2024231,800 shares $394.06 thousand -9.2%5.7%0 $1.70 9/30/2024255,300 shares $495.28 thousand +45.4%6.3%0.1 $1.94 9/15/2024175,600 shares $454.80 thousand -72.2%4.3%0 $2.59 8/31/2024632,400 shares $2.95 million +142.7%15.6%0.1 $4.66 8/15/2024260,600 shares $362.23 thousand +1,278.8%12.6%0.1 $1.39 7/31/202418,900 shares $23.53 thousand -54.2%1.1%0 $1.25 7/15/202441,300 shares $46.67 thousand -36.6%2.4%0 $1.13 6/30/202465,100 shares $75.52 thousand -75.6%3.8%0 $1.16 6/15/2024266,800 shares $482.91 thousand +467.7%15.4%0.2 $1.81 5/31/202447,000 shares $55.46 thousand +7,733.3%2.7%0 $1.18 5/15/2024600 shares $476.10 -14.3%0.0%0 $0.79 4/30/2024700 shares $441.00 -94.2%0.0%0 $0.63 4/15/202412,000 shares $8.10 thousand +300.0%0.7%0.2 $0.68 3/31/20243,000 shares $2.15 thousand -80.9%0.2%0 $0.72 3/15/202415,700 shares $13.28 thousand -74.1%1.2%0.1 $0.85 2/29/202460,600 shares $58.33 thousand +9.2%4.6%0.4 $0.96 2/15/202455,500 shares $45.63 thousand -44.8%4.2%0.4 $0.82 1/31/2024100,500 shares $82.41 thousand +233.9%8.5%0.8 $0.82 1/15/202430,100 shares $31.00 thousand -78.3%2.6%0.4 $1.03 12/31/2023138,600 shares $202.36 thousand +6,500.0%7.7%1.9 $1.46 12/15/20232,100 shares $3.33 thousand -93.1%0.0%0 $1.59 11/30/202330,200 shares $7.02 thousand -39.8%0.3%0.2 $0.23 11/15/202350,200 shares $12.75 thousand -30.4%0.5%0.3 $0.25 10/31/202372,100 shares $17.69 thousand -24.7%0.8%0.4 $0.25 10/15/202395,700 shares $28.33 thousand -24.1%1.0%0.6 $0.30 9/30/2023126,000 shares $40.95 thousand -32.9%1.4%0.7 $0.33 9/15/2023187,800 shares $67.89 thousand +476.1%2.0%1.1 $0.36 8/31/202332,600 shares $11.67 thousand +565.3%0.4%0.1 $0.36 8/15/20234,900 shares $1.89 thousand -80.3%0.1%0 $0.39 7/31/202324,900 shares $9.82 thousand -48.2%0.3%0.1 $0.39 7/15/202348,100 shares $19.20 thousand -68.9%0.5%0.2 $0.40 6/30/2023154,400 shares $60.20 thousand -46.2%1.7%0.3 $0.39 6/15/2023286,700 shares $117.20 thousand +42.2%3.1%0.5 $0.41 5/31/2023201,600 shares $78.97 thousand +0.6%3.2%0.4 $0.39 5/15/2023200,500 shares $70.40 thousand No Change3.1%0.1 $0.35 VRAX Short Interest - Frequently Asked Questions What is Virax Biolabs Group's current short interest? Short interest is the volume of Virax Biolabs Group shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 139,500 shares of VRAX short. 3.58% of Virax Biolabs Group's shares are currently sold short. Learn More on Virax Biolabs Group's current short interest. What is a good short interest percentage for Virax Biolabs Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.58% of Virax Biolabs Group's floating shares are currently sold short. Is Virax Biolabs Group's short interest increasing or decreasing? Virax Biolabs Group saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 139,500 shares, a drop of 60.2% from the previous total of 350,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virax Biolabs Group's float size? Virax Biolabs Group currently has issued a total of 4,340,000 shares. Some of Virax Biolabs Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virax Biolabs Group currently has a public float of 3,900,000 shares. How does Virax Biolabs Group's short interest compare to its competitors? 3.58% of Virax Biolabs Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virax Biolabs Group: Aspire Biopharma Holdings, Inc. (5.74%), IM Cannabis Corp. (0.38%), Flora Growth Corp. (2.76%), Biofrontera Inc. (1.59%), IN8bio, Inc. (1.62%), Addex Therapeutics Ltd. Sponsored ADR (5.61%), Qualigen Therapeutics, Inc. (2.53%), Heatwurx Inc. (1.81%), Matinas Biopharma Holdings, Inc. (3.63%), Kiora Pharmaceuticals, Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Virax Biolabs Group stock? Short selling VRAX is an investing strategy that aims to generate trading profit from Virax Biolabs Group as its price is falling. VRAX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virax Biolabs Group? A short squeeze for Virax Biolabs Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRAX, which in turn drives the price of the stock up even further. How often is Virax Biolabs Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRAX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies ASBP Short Interest IMCC Short Interest FLGC Short Interest BFRI Short Interest INAB Short Interest ADXN Short Interest QLGN Short Interest PCSA Short Interest MTNB Short Interest KPRX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRAX) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAX Stock Alerts